Sign in to continue:

Saturday, January 31st, 2026
Stock Profile: DAWN
DAWN Logo

Day One Biopharmaceuticals, Inc. (DAWN)

Market: NMS | Currency: USD

Address: 2000 Sierra Point Parkway

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.




๐Ÿ“ˆ Day One Biopharmaceuticals, Inc. Historical Chart






๐Ÿ“Š Statistics





๐Ÿ’ฐ Dividend History


No dividend history available.



๐Ÿ“… Earnings & EPS History for Day One Biopharmaceuticals, Inc.


DateReported EPS
2026-02-24 (estimated upcoming)-
2025-11-04-0.19
2025-08-05-0.29
2025-05-06-0.35
2025-02-25-0.63
2024-10-300.38
2024-07-30-0.05
2024-05-06-0.72
2024-02-26-0.64
2023-11-06-0.54
2023-08-07-0.61
2023-05-01-0.59
2023-03-06-0.56
2022-11-07-0.53
2022-08-04-0.6
2022-05-12-0.48
2022-03-07-0.35
2021-11-08-0.33
2021-08-10-5.04




๐Ÿ“ฐ Related News & Research


๐Ÿ” View more Reports